返回搜索
档案
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
发明专利审中
10浏览
20权利要求 · 7 独立
§ Ⅰ
卷宗概要
发明人
Hubert BORELL; Anne GARDIN; Yi JIN; Eric LEGANGNEUX; Mike UFER
IPC 分类
C7D 205/4C12Q 1/6883G1N 33/50G1N 33/569
CPC 分类
C7D205/4C12Q1/6883G1N33/5094G1N33/56972C12Q2600/106C12Q2600/156G1N2800/52
The invention provides a method of assessing the appropriate therapeutic dose of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid to administer to a patient in need thereof, comprising the steps of:
原文（中文）
The invention provides a method of assessing the appropriate therapeutic dose of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid to administer to a patient in need thereof, comprising the steps of: